Infectious Disease Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Infectious Disease Market
1.1. Definition and Scope
1.1.1. Definition of Infectious Disease
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Infectious Disease Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Infectious Disease Market By Product
1.2.3. Infectious Disease Market By Technology
1.2.4. Infectious Disease Market By Application
1.2.5. Infectious Disease Market By End-User
1.2.6. Infectious Disease Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Infectious Disease Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Infectious Disease Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Infectious Disease Market By Product
5.1. Introduction
5.2. Infectious Disease Revenue By Product
5.2.1. Infectious Disease Revenue (USD Billion) and Forecast, By Product, 2020-2032
5.2.2. Instruments
5.2.2.1. Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Assays and Reagents
5.2.3.1. Assays and Reagents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Services
5.2.4.1. Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Infectious Disease Market By Technology
6.1. Introduction
6.2. Infectious Disease Revenue By Technology
6.2.1. Infectious Disease Revenue (USD Billion) and Forecast, By Technology, 2020-2032
6.2.2. Clinical In Situ Hybridization
6.2.2.1. Clinical In Situ Hybridization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Polymerase chain reaction (PCR)
6.2.3.1. Polymerase chain reaction (PCR) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. In Situ Hybridization
6.2.4.1. In Situ Hybridization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.2.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Immunodiagnostics
6.2.6.1. Immunodiagnostics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Other Technology
6.2.7.1. Other Technology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Infectious Disease Market By Application
7.1. Introduction
7.2. Infectious Disease Revenue By Application
7.2.1. Infectious Disease Revenue (USD Billion) and Forecast, By Application, 2020-2032
7.2.2. Hepatitis
7.2.2.1. Hepatitis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Human Immunodeficiency Virus
7.2.3.1. Human Immunodeficiency Virus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Chlamydia Trachomatis Genital Infection and Gonorrhea
7.2.4.1. Chlamydia Trachomatis Genital Infection and Gonorrhea Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Hospital-Acquired Infections
7.2.5.1. Hospital-Acquired Infections Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Human Papillomavirus
7.2.6.1. Human Papillomavirus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.7. Tuberculosis
7.2.7.1. Tuberculosis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.8. Influenza
7.2.8.1. Influenza Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.9. COVID-19
7.2.9.1. COVID-19 Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.10. Others
7.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Infectious Disease Market By End-User
8.1. Introduction
8.2. Infectious Disease Revenue By End-User
8.2.1. Infectious Disease Revenue (USD Billion) and Forecast, By End-User, 2020-2032
8.2.2. Hospitals and Clinics
8.2.2.1. Hospitals and Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Research Institutes
8.2.3.1. Research Institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Pharmaceutical Companies
8.2.4.1. Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Infectious Disease Market By Country
9.1. North America Infectious Disease Market Overview
9.2. U.S.
9.2.1. U.S. Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. U.S. Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
9.2.3. U.S. Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.4. U.S. Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Canada
9.3.1. Canada Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Canada Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
9.3.3. Canada Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.4. Canada Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Infectious Disease Market By Country
10.1. Europe Infectious Disease Market Overview
10.2. U.K.
10.2.1. U.K. Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. U.K. Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.2.3. U.K. Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.4. U.K. Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Germany
10.3.1. Germany Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Germany Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.3.3. Germany Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.4. Germany Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. France
10.4.1. France Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. France Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.4.3. France Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.4. France Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Spain
10.5.1. Spain Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.2. Spain Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.5.3. Spain Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.4. Spain Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.2. Rest of Europe Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.6.3. Rest of Europe Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Infectious Disease Market By Country
11.1. Asia Pacific Infectious Disease Market Overview
11.2. China
11.2.1. China Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. China Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.2.3. China Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.4. China Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. Japan
11.3.1. Japan Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Japan Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.3.3. Japan Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.4. Japan Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. India
11.4.1. India Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. India Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.4.3. India Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.4. India Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Australia
11.5.1. Australia Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5.2. Australia Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.5.3. Australia Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
11.5.4. Australia Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.6. South Korea
11.6.1. South Korea Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
11.6.2. South Korea Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.6.3. South Korea Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
11.6.4. South Korea Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
11.7.2. Rest of Asia-Pacific Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.7.3. Rest of Asia-Pacific Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Infectious Disease Market By Country
12.1. Latin America Infectious Disease Market Overview
12.2. Brazil
12.2.1. Brazil Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. Brazil Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.2.3. Brazil Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.4. Brazil Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.3. Mexico
12.3.1. Mexico Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. Mexico Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.3.3. Mexico Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.4. Mexico Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. Rest of Latin America Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.4.3. Rest of Latin America Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Infectious Disease Market By Country
13.1. Middle East & Africa Infectious Disease Market Overview
13.2. GCC
13.2.1. GCC Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
13.2.2. GCC Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.2.3. GCC Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.4. GCC Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.3. South Africa
13.3.1. South Africa Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
13.3.2. South Africa Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.3.3. South Africa Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.4. South Africa Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Infectious Disease Revenue (USD Billion) and Forecast By Product, 2020-2032
13.4.2. Rest of Middle East & Africa Infectious Disease Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.4.3. Rest of Middle East & Africa Infectious Disease Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Infectious Disease Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Infectious Disease Market
14.1. Infectious Disease Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Infectious Disease Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Abbott
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Abbott 2022 Infectious Disease Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. BD
15.3. bioMérieux
15.4. Bio-Rad Laboratories Inc.
15.5. Danaher
15.6. DiaSorin S.p.A.
15.7. Meridian Bioscience Inc.
15.8. Quidel Corporation, Siemens
15.9. Thermo Fisher Scientific Inc.
15.10. Johnson and Johnson Private Limited
15.11. F. Hoffmann-La Roche Ltd
15.12. Cepheid
15.13. Qiagen
15.14. OraSure Technologies, Inc.
Frequently Asked Questions
How big is the infectious disease market?
The infectious disease market size was USD 26.4 billion in 2022.
What is the CAGR of the global infectious disease market from 2023 to 2032?
The CAGR of infectious disease is 6.9% during the analysis period of 2023 to 2032.
Which are the key players in the infectious disease market?
The key players operating in the global market are including Abbott, BD, bioMérieux, Bio-Rad Laboratories Inc., Danaher, DiaSorin S.p.A., Meridian Bioscience Inc., Quidel Corporation, Siemens, Thermo Fisher Scientific Inc., Johnson and Johnson Private Limited, F. Hoffmann-La Roche Ltd, Cepheid, Qiagen, and OraSure Technologies, Inc.
Which region dominated the global infectious disease market share?
North America held the dominating position in infectious disease industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of infectious disease during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global infectious disease industry?
The current trends and dynamics in the infectious disease industry include technological advancements in diagnostic tools and treatments, rising global incidence of infectious diseases, increased funding for research and development, and growing awareness and initiatives for disease prevention.
Which product held the maximum share in 2022?
The assays and reagents product held the maximum share of the infectious disease industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
